Santai Labs Inc.

Santai Labs, Inc. is a pharmaceutical research and development outsourcing service company founded by overseas returnees studying in the United States. With rich professional experience and resource advantages in chemical synthesis, pharmaceutical chemistry, and biotechnology, Santai Labs is committed to providing high value-added products and services for global pharmaceutical and biotechnology companies, helping customers reduce the cost of new drug development and shorten the time to market for new drugs. As a professional commissioned experimental institution, the company has a research and development team composed of several returnees with different levels of talent, including doctoral, master's, and undergraduate degrees. The team members have years of experience working in top pharmaceutical companies, biotechnology companies, and CRO companies both domestically and internationally. They possess multiple patent achievements and high-level academic papers, accumulating highly competitive technical resources and extensive customer resources. Since its establishment, the company has established stable cooperative relationships with well-known domestic pharmaceutical production enterprises in a short period of time through flexible cooperation methods, professional and fast services, and good reputation, laying a solid foundation for future development. At present, we can provide services such as customized synthesis business from milligrams to kilograms, core structure design and research and development, optimization of drug precursor structures, process research and development, production of pilot to large-scale active pharmaceutical ingredients, FTE FFS project services, design and synthesis of small molecule compound libraries, and early research services. We adhere to the spirit of customer first pursuit of excellence, continuously expand the capabilities of enterprises in all aspects, actively strive to build world-class pharmaceutical research and development outsourcing services and new drug development platforms, provide better services for domestic and foreign customers, meet their increasing needs, and contribute to the fight against diseases for humanity.